Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator
Thousands of oncology experts from around the world will gather in Chicago from April 14 - 18 for the AACR Annual Meeting. Memorial Sloan Kettering experts are involved in notable research presented at the meeting and are available to comment on precision medicine, immunotherapy, interception and prevention, liquid biopsies, genomics and more. For more information and to set up interviews or access photos and video, email Nicole H. McNamara at firstname.lastname@example.org
Thursday, April 12, 2018
Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories.
Friday, April 6, 2018
Larotrectinib, a highly selective TRK kinase inhibitor, shows rapid, potent, and durable efficacy in both adult and pediatric patients with solid tumors that harbor TRK fusions, regardless of tumor type or patient age, according to results from three clinical trials published in the New England Journal of Medicine. The landmark data support the foundation of precision oncology by creating a treatment option for a genetically defined cancer while continuing to validate the concept that comprehensive molecular profiling should be strongly considered in people of all ages with advanced solid tumors.
Wednesday, February 21, 2018
See all trending topics